ABO BLOOD GROUPS AND FREQUENCY OF ACQUIRED B-ANTIGEN AMONG SUDANESE COLORECTAL CARCINOMA PATIENTS 2016
Journal Title: European Journal of Biomedical and Pharmaceutical Sciences - Year 2017, Vol 4, Issue 9
Abstract
Background: Colorectal cancer (CRC) is the third-most commonly diagnosed cancer in males and the second-most common in females. Cancer is an increasingly important public health problem in developing countries, including Sudan. The burden of colorectal cancer in Sudan is unknown, mainly because of lack of statistics or under reporting. Colorectal carcinoma is the most common malignancy of the GI tract, unfortunately there are few statistical data regarding colorectal cancer, its geographical, ethnic distribution, & pattern of behavior in Sudan. Conducting ABO blood group among those patients, can help determine the presence of acquired B-antigen that can affect the choice of blood for transfusion moreover no studies were published about acquiring B-antigen in Sudan. Objective: This study aimed to investigate, the prevalence of ABO Blood groups among Sudanese patients with colorectal carcinoma, to determine the association of acquired B-antigen using direct and indirect blood grouping and to correlate the acquired B-antigen with patient`s age, gender and duration of colorectal cancer. Materials and Methods: This is a prospective case-control hospital-based study conducted in RICK in Khartoum, Sudan from November 2016- February 2017. This study included fifty colorectal carcinoma patients as cases, Control group included (50) volunteers. Direct and indirect blood grouping were done to case and control groups frequently of each blood group was determined. Results: mean (+/- SD) of age among cases 43 (+/-9.9) was higher than control group 39 (+/- 11.1), The mean of disease duration was 7 (+/-3) months. Males among case and control groups were (60%), (64%) respectively. The direct and indirect blood grouping of cases revealed the following; A+ve, B+ve, O+ve and AB+ve were; (32%), (16%), (48%), and (4%), respectively. Among control group, A+ve, B+ve, O+ve and AB+ve were; (28%), (22%), (44%) and (6%), respectively. No significant differences between groups (p=.835) and the presence Acquired B-Antigen was not observed among case and control groups. Conclusion: This study concluded that no effects of colorectal cancer on ABO blood groups and no evidence of acquired B-antigen among cases.
Authors and Affiliations
Khalid Omer Ahmed Suliman
PHASE SHIFT IN BMAL1 MRNA CIRCADIAN RHYTHM INCREASES CHOLESTEROL AND TRIGLYCERIDES IN MALE RATS MAINTAINED UNDER ALTERED LIGHT-DARK CYCLE
Advances in technology and modern life style cause a production of 24h society, that accompanied by increased exposure to light at night. This phenomenon may have harmful effects on human health that result from disrupti...
ANTIBIOTICS SUSCEPTIBILITY PATTERNS OF STAPHYLOCOCCUS AUREUS IN CLINICAL ISOLATES FROM MAITAMA DISTRICT HOSPITAL, ABUJA, NIGERIA
Staphylococcus aureus is a major pathogen causing a variety of infections ranging from mild skin infections to life threatening systemic illness. Antibiotic resistance by Methicillin Resistant Staphylococcus Aureus (MRSA...
PARAQUAT POISONING AND PARAQUAT MORTALITY IN PATIENTS REFERRED TO AHVAZ TEACHING HOSPITALS
Introduction: Today poisoning with pesticides has increased and Poisoning with paraquat is one of the most significant poisoning in patients. The aim of this study was to investigate paraquat poisoning and mortality rate...
ANTICANDIDAL ACTIVITY OF ETHANOLIC EXTRACT OF CLOVE AGAINST CLINICAL ISOLATES OF CANDIDA
The incidence of both community acquired and hospital acquired mycotic infections has significantly elevated since past few decades, in accounts of growing number of high risk patients, those with impaired immunity.[1] O...
ENDOMETRIAL STROMAL SARCOMA AND THE DIAGNOSTIC RELIABILITY OF CD10: A CASE REPORT AND REVIEW OF LITERATURE
Endometrial stromal sarcoma represents 0.2% of all uterine malignancies. This establishes its rarity as a gynaecologic malignancy, although it is second to uterine leiomyosarcoma among mesenchymal uterine tumours. It al...